Allocation concealment and blinding: when ignorance is bliss
Author: Vance W Berger
Published online: 1 August 2005
To the Editor: Forder et al conveyed that trials without allocation concealment have the potential to mislead.1 However, it is not true in any meaningful sense that “Without exception, allocation concealment is achievable in all randomised clinical trials. In contrast, it is not always possible to blind people to study treatments received.” Rather, “Masking may be defined as either the process (researchers not revealing treatment codes until the database is locked) or the result (complete ignorance of all trial participants as to which patients received which treatments). A masking claim indicates only the former . . . If masking is possible only some of the time, then clearly reference is being made to the result, and not the process. To be fair, then, one would have to ask if the result of allocation concealment is always possible . . . only the process of allocation concealment, but not its result, can be ensured.”2
Forder et al also state that certain methods (including sealed envelopes) are considered to be adequate concealment methods. Sadly, this is true, but only if the emphasis is on the word “considered”, because sealed envelopes are both imperfect at preventing direct observation of future allocations and useless at preventing the prediction of future allocations, even without direct observation. Because the extent of prediction depends on the specific restrictions used on the randomisation,3 allocation concealment is not even a binary phenomenon, and so to truly assess allocation concealment in a given trial, one must ask how much prediction is possible in that trial.
Allocation concealment is perfect if no observation or prediction is possible, and only partially effective if some prediction is possible. Many trials use randomised blocks, and smaller block sizes tend to allow for substantial prediction.3-5 So, while methods aimed only at preventing the direct observations of future allocations may be considered to be adequate, it is clear that in reality they are not.
That the authors failed to use this opportunity to set the record straight indicates their implicit agreement with the incorrect statement that methods aimed only at preventing the direct observations of future allocations are not only considered adequate, but actually are adequate. Pretending that allocation concealment is binary, and hence that it suffices to use methods aimed only at preventing the direct observations of future allocations, represents ignorance that may be bliss, but certainly is not harmless.
References
- Forder PM, Gebski VJ, Keech AC. Allocation concealment and blinding: when ignorance is bliss. Med J Aust 2005; 182: 87-89.
- Berger VW, Christophi CA. Randomization technique, allocation concealment, masking, and susceptibility of trials to selection bias. J Mod Appl of Stat Methods 2003 2: 80-86. i1085834
- Berger VW, Ivanova A, Deloria-Knoll M. Minimizing predictability while retaining balance through the use of less restrictive randomization procedures. Stat Med 2003; 22: 3017-3028. i1085836
- Berger VW. Quantifying the magnitude of baseline covariate imbalances resulting from selection bias in randomized clinical trials (with discussion). Biometr J 2005; 47: 119-139.
- Berger VW. Selection bias and covariate imbalances in clinical trials. Chichester: John Wiley & Sons, 2005. i1085839
Interpreting Australian Stillbirth Rate Trends: Implications for Surveillance and Continuous Quality Improvement
Aleena M. Wojcieszek, Kirstine Sketcher-Baker, Christine Andrews, Michael Coory, Imogen Kettle, Melissa Malivoire, David Ellwood, Vicki Flenady
Paracetamol in Pregnancy: Uncertain Evidence, Certain Consequences
David J. Tunnicliffe, Miranda Cumpston, Debra Kennedy, Margie Danchin, Armando Teixeira-Pinto
Fatty Liver Disease in Australia: A Narrative Review on the Epidemiology, Natural History, Prognostication and Management in People With Metabolic Dysfunction
Karl Vaz, Daniel Clayton-Chubb, William W. Kemp, Stuart K. Roberts, Ammar Majeed
Birth prevalence, clinical sequelae, and management of congenital cytomegalovirus infections in Australia, 1999–2023: a national prospective study
Ece Egilmezer, Suzy M Teutsch, Carlos Nunez, Stuart T Hamilton, Adam W Bartlett, Pamela Palasanthiran, Elizabeth J Elliott, William D Rawlinson
The number of cancer‐related deaths that could be attributable to spatial disparities in survival in Australia, 2010–2019: a retrospective population‐based cohort study
Charlotte K Bainomugisa, Jessica Cameron, Paramita Dasgupta, Peter Baade
Mandatory research projects during medical specialist training in Australia and New Zealand
Paulina Stehlik, Caitlin Brandenburg, David A Henry